- $300.86bn
- $308.18bn
- $33.72bn
- 99
- 15
- 90
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20,156 | 24,996 | 29,698 | 31,616 | 33,723 |
Cost of Revenue | |||||
Gross Profit | 7,716 | 10,821 | 12,365 | 12,447 | 14,008 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 17,552 | 20,411 | 23,503 | 25,983 | 26,769 |
Operating Profit | 2,604 | 4,585 | 6,195 | 5,633 | 6,954 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2,062 | 3,199 | 5,840 | 5,264 | 6,205 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,739 | 2,674 | 4,861 | 4,123 | 5,408 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,867 | 2,761 | 5,116 | 4,492 | 5,408 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,867 | 2,761 | 5,116 | 4,492 | 5,408 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.85 | 7.91 | 10.7 | 9.14 | 12 |